Emphysema Secondary to Congenital AATD
1 clinical trials · Condition
◉ Watch Emphysema Secondary to Congenital AATD
| Record | Firm | Date |
|---|---|---|
| Study of OsrhAAT or Placebo in Healthy Volunteers (NCT05315921) | Healthgen Biotechnology Corp. | 2022-03-22 |
Track Emphysema Secondary to Congenital AATD automatically
Every clearance here is in the API, with alerts when new ones post.